Publication | Closed Access

Novel lead generation of an anti-tuberculosis agent active against non-replicating mycobacteria: exploring hybridization of pyrazinamide with multiple fragments

Pulmonary TuberculosisMedicineAnti-tuberculosis AgentTuberculosisNovel Lead GenerationAntibacterial AgentMicrobiologyAntimicrobial ChemotherapyAntimicrobial CompoundPharmacologyMultiple FragmentsDrug DiscoveryDrug Resistance